Sweden· SE-20220525000017
Enrylaze 10 mg/0,5 ml Injektions-/infusionsvätska, lösning
A medicinal product containing recombinant l-asparaginase, registered in Sweden by Jazz Pharmaceuticals Ireland Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Recombinant L-Asparaginase
- Manufacturer
- Jazz Pharmaceuticals Ireland Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20220525000017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Recombinant l-asparaginase in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayEnrylazeJazz Pharmaceuticals Ireland Limited
- United KingdomAsparaginase 10,000unit powder for solution for injection vialsSpecial Order
- BelgiumParonal 10000 IUTakeda Belgium
- CzechiaSPECTRILAMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- JapanＬ－アスパラギナーゼ協和キリン
- IcelandSpectrilamedac Gesellschaft für klinische Spezialpräparate GmbH
- PolandSpectrilamedac Gesellschaft fuer klinische Spezialpraeparate mbH
- United StatesRylazeJazz Pharmaceuticals, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Enrylaze, Spectrila
- Liechtenstein · Enrylaze, Spectrila
- Norway · Enrylaze, Spectrila
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3578f5f-9dac-4f89-b3f9-ae7a64964575 GET /v1/drugs/f3578f5f-9dac-4f89-b3f9-ae7a64964575?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20220525000017",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20220525000017",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/enrylaze"
}See everything about recombinant l-asparaginase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.